Fermentalg S.A.
FALG.PA
Euronext Paris0.56
EUR
-0.05
- -
Fermentalg S.A.
FALG.PA
(Euronext Paris)
Recent
price
0.56
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Fermentalg SA develops, produces and sells high-value biosolutions derived from microalgae fermentation for the nutrition, health, food, feed and environmental sectors in Europe, North America, Asia and internationally. Founded in 2009 and headquartered in Libourne, France, the company offers DHA ORIGINS, a vegan plant-based DHA omega-3 oil from Schizochytrium sp. for infant nutrition, dietary supplements, functional foods, pet nutrition and aquafeed; KALVEA PLUS, a protein concentrate for aquafeed; Everzure, an acid-stable natural blue phycocyanin colorant; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory extract; BLUE ORIGIN, a natural blue colorant; and CO2 capture solutions including biobased raw materials via its CarbonWorks joint venture with Suez. Fermentalg operates through precision fermentation technology that enhances productivity using sugars rather than sunlight, targeting sustainable omega-3s, alternative proteins and natural pigments amid growing demand for plant-based and eco-friendly ingredients. In June 2024, the company completed a 12.8 million euro capital increase led by industrial partner Huvepharma, which entered its capital and strengthened a long-term manufacturing alliance for omega-3 production at ADL Biopharma's facility; Huvepharma's involvement also supports European algal omega-3 sovereignty. In May 2025, the US FDA approved Fermentalg's natural blue dye, enabling commercialization of Everzure and related phycocyanin products for beverages and other markets; the company reported 36% first-quarter 2025 revenue growth and improved 2024 results driven by sales momentum, margin expansion and destocking optimization. Additional partnerships include a multi-year deal with DDW for phycocyanin industrialization and GOED membership for omega-3 quality standards.